Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
VRTX
VRTX News & Events
-
Add to Watchlist
Trade VRTX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
VRTX News
Vertex Pharmaceuticals Poised for Significant Growth in 2026
3 hours ago
Fool
Pharma Stocks on the Verge of a Breakthrough: Earnings May Propel Them Forward.
1 day ago
Barron's
Avant Technologies Leads Transformation in Healthcare Market
3 days ago
PRnewswire
Avant Technologies Leads Medical Innovation with Next-Gen Treatments
3 days ago
Newsfilter
Avant Technologies Unveils Cell Encapsulation Tech to Address 589 Million Diabetes Patients' Needs
5 days ago
Globenewswire
Avant Technologies Unveils Cell Encapsulation Tech, Tapping into Diabetes Market Potential
5 days ago
Newsfilter
Vertex Pharmaceuticals Up 30%, Analyst Upgrades to Outperform with $546 Target
6 days ago
Benzinga
RBC Upgrades Vertex Pharmaceuticals (VRTX) to Outperform, Forecasting $12.5B-$13.5B Sales by 2026
Jan 22 2026
seekingalpha
Show More News
VRTX Events
01/22 15:10
Vertex Pharmaceuticals' povetacicept Granted FDA Orphan Designation
Vertex Pharmaceuticals' povetacicept was granted FDA orphan designation as a treatment of membranous nephropathy, according to a post to the agency's website.
Show More Events
VRTX Monitor News
Vertex Pharmaceuticals reaches 5-day high amid market strength
Jan 21 2026
Vertex Pharmaceuticals reaches 20-day high amid market strength
Jan 07 2026
Vertex Pharmaceuticals reaches 20-day high amid sector rotation
Jan 06 2026
Vertex Pharmaceuticals Hits 20-Day High on Analyst Upgrades
Dec 03 2025
VRTX Earnings Analysis
Vertex Pharmaceuticals: Strong Q3 2025 Earnings- Intellectia AI™
2 months ago
Vertex Pharmaceuticals Soars with Key Approvals and Product Expansion - Intellectia AI™
11 months ago
People Also Watch
